Impact of Vaccine Funding by the National Health Insurance on Vaccination Coverage Among Patients Targeted by Current Vaccination Recommendations and Followed in Outpatient Consultations

Recruiting Observational Study
Healthcare Providers Postpartum
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
2,920 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The objective of our study is to evaluate the impact of vaccine funding for patients seen in outpatient consultations within four healthcare institutions in the Ile-de-France region in France, made possible through the establishment of a tripartite agreement between the hospital group, the Île-de-France Regional Health Agency (ARS IDF), and the Primary Health Insurance Fund (CPAM).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: For patients: 1. For the assessment of pneumococcal coverage among patients eligible for this vaccination: * Individuals aged 18 years or older, * Individuals followed in outpatient consultations within a department and healthcare institution participating in the project…
Contacts

Marie LACHATRE, MD

0033158412093

marie.lachatre@aphp.fr

CONTACT

Marie BENHAMMANI-GODARD

0033158411190

marie.godard@aphp.fr

CONTACT